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Abstract
Echocardiographic indicators in decompensated heart failure demonstrate a high prevalence of structural and
hemodynamic abnormalities. In the patients with decompensated heart failure in the early and late post-infarction
period, echocardiographic indicators were found to significantly differ from those recorded in the patients without
heart failure. Thus, reduced ejection fraction, increased end-diastolic volume and end-diastolic dimension
indicate left ventricular systolic dysfunction and left ventricular cavity dilation. Since echocardiography of the
heart and the pulmonary artery enables real-time estimation of cardiac filling, signs of systolic dysfunction and
pulmonary congestion, it may serve as a predictor of decompensated heart failure development in the early and
late post-infarction period.
The objective of the research was to determine the main echocardiographic indicators in terms of rapid moni-
toring of deterioration in the main parameters of left ventricular overload for early diagnosis of decompensated
heart failure, as well as structural and geometric remodeling of left ventricular myocardium in the early and late
post-infarction period.
Materials and methods. There were examined 160 patients with acute myocardial infarction. Depending on
the development of decompensated heart failure in the early and late post-infarction period, the patients were
divided into two subgroups being homogeneous by age and gender.
Results. The results obtained indicated significant hemodynamic changes in the patients with decompensated
heart failure in the post-infarction period. They included significantly lower values of ejection fraction indicating
left ventricular systolic dysfunction and the signs of left ventricular cavity dilation as evidenced by the increase in
left ventricular end-diastolic volume and end-diastolic dimension. The tendency for an increase in left ventricular
posterior wall thickness and interventricular septal thickness, as well as left ventricular myocardial mass, left
ventricular myocardial mass index and left ventricular radius to wall thickness ratio indicated concentric left
ventricular remodeling.
Conclusions. Modern management of patients with decompensated heart failure should be guided by an
objective value of left ventricular ejection fraction as it plays a key role in selecting management strategy for this
cohort of patients since a significant reduction in this parameter indicates cardiac decompensation. Pulmonary
artery pressure and concentric left ventricular hypertrophy play a significant role in cardiac failure development
as well.
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Problem statement and analysis of
the latest research
Cardiovascular diseases (CVD) are known to ac-
count for one-third of all deaths worldwide [3]. Ac-
cording to the American Heart Association, 18%
of men and 35% of women with prior acute my-
ocardial infarction (AMI) developed recurrent AMI
within 6 years after initial MI; 22% of men and
46% of women were disabled due to the develop-
ment of chronic heart failure (CHF) [1]. Due to
the improvement of the methods for AMI diagnosis
and treatment, the mortality rate has significantly
decreased. This contributed to the increase in the
number of the patients who survived initial and re-
current episodes; thus, the number of the patients
with the signs of CHF and its decompensation in-
creased as well [4]. Moreover, as the age of the
population increased, treatment of acute coronary
syndrome and comorbidities improved, epidemiol-
ogy of HF changed significantly as well [6]. HF
is a global pandemic; its prevalence is constantly
increasing worldwide [16]. The patients with acute
or decompensated HF represent a heterogeneous
group of patients with various causes of the devel-
opment or exacerbation of this disease and hemody-
namic phenotypes [14, 9]. Screening and risk strat-
ification for congestive HF are the most common
and urgent problem of modern cardiological soci-
ety [5]. Echocardiography plays a significant role
in diagnosing HF both in practice and multicenter
clinical trials [13]. Despite this fact, echocardio-
graphic study being used in phase II and phase III
HF clinical trials, is not used in clinical practice.
For example, some multicenter clinical trials con-
sidered left ventricular (LV) ejection fraction (EF)
as a single structural indicator of HF prediction
[7]. Therefore, it is unclear whether echocardio-
graphy, as an examination method, can serve as
a tool for classifying and determining the risk of
CHF decompensation in the post-infarction period.
Echocardiographic indicators in the patients with
acute and decompensated HF cannot be objectively
described due to countless causes and pathophysio-
logical mechanisms being involved in the formation
of this syndrome; moreover, nowadays there is no
strict definition of acute HF [10]. Clinical symp-
toms and exercise intolerance are limited predictors
of LV systolic dysfunction [8]. According to current
guidelines on HF management, daily assessment of
the signs and symptoms, fluid balance, vital func-
tions, body weight and renal dysfunction should be
carried out in patients hospitalized due to HF de-
compensation to select decongestive therapy, since
natriuretic peptide determination turned out to be
ineffective for routine treatment of the patients with
prior acute HF [15]. The degree of LV remodel-
ing is an important prognostic factor in the patients
with decompensated HF and reduced LVEF [11].
Since MI is the most frequent trigger causative for
the development of LV remodeling, these patients
require continuous and careful clinical and instru-
mental monitoring to provide adequate treatment
and prevent CHF development including its decom-
pensation in the post-infarction period [2]. Cardiac
remodeling is the best term to describe the process
able to modify the molecules and genes within the
cell, as well as the extracellular matrix that repre-
sents the formation of HF syndrome [12].
The objective of the research was to deter-
mine the main echocardiographic indicators in terms
of rapid monitoring of deterioration in the main
parameters of LV overload for early diagnosis of
decompensated HF, as well as structural and geo-
metric remodeling of LV myocardium in the early
and late post-infarction period.
1. Materials and Methods
The study was carried out in the infraction depart-
ment No 2 of the Ivano-Frankivsk Regional Clini-
cal Cardiology Dispensary and the Department of
Internal Medicine No 2 and Nursing of the Ivano-
Frankivsk National Medical University. There were
examined 160 patients with prior MI; the average
age was (56.67±5.72) years. All the patients were
divided into 2 groups depending on the presence
of signs of stage II A-B decompensated chronic
HF according to the classification by Vasylenko
V.Kh. and Strazhesko M.D., the New York Heart
Association (NYHA) functional class (FC) III-IV.
Group I (the main group) included 120 patients with
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prior Q-QS wave MI or non-Q wave MI; Group II
(the control group) comprised 40 patients with prior
MI without any signs of decompensated HF. Inclu-
sion criterion was prior Q-QS wave MI or non-Q
wave MI occurred within 28 days before the re-
search started. Study groups were homogenous by
age, gender, disease severity, duration of the post-
infarction period, clinical signs of decompensation.
Clinical diagnosis was made in accordance with the
European Society of Cardiology Guidelines, on the
basis of anamnestic data, physical examination, lab-
oratory and instrumental findings, namely urine and
blood tests, electrocardiography, echocardiography,
chest X-ray.
In all the patients, the indicators of remodel-
ing (architectonic changes and changes in LV func-
tion with connective tissue expansion in neurohu-
moral activation due to post-infarction cardiosclero-
sis, stunned myocardium, hibernating myocardium,
transient ischemia), LV end-diastolic dimension
(EDD), LV end-diastolic volume (EDV), LV inter-
ventricular septal thickness (IVST) in systole and
diastole, LV posterior wall thickness (PVT) in sys-
tole and diastole, LV myocardial mass (MM), LV
myocardial mass index (MMI), LV radius to wall
thickness ratio were assessed. LVEF was also as-
sessed by Simpson’s rule, since according to the
recommendations of the American College of Car-
diology and the American Heart Association, EF
findings after AMI are determined as Class I, level
of evidence B. Thus, LVEF in the range of 40 -
49% was considered as borderline LV dysfunction;
LVEF >50% was defined as preserved LV func-
tion; LVEF < 40% was considered as reduced LV
systolic function
The results obtained were statistically processed
by means of an advanced analytics software pack-
age STATISTICA-7 and a statistical software pack-
age ”Microsoft-Excel” using the statistical variation
analysis. There were calculated the mean M, the
mean squared error δ , the standard error of the
mean m, the sample size (n). P-value was consid-
ered significant at p<0.05.
2. Results and Discussion
Echocardiographic indicators indicated significant
changes in metric and volumetric indicators of LV
and its contractility in the patients with decom-
pensated HF (Table 1). Both LVEDV and end-
systolic volume (ESV) were significantly higher
as compared to healthy individuals without decom-
pensated HF. This was probably due to the high-
est indicators of the EDD and end-systolic dimen-
sion (ESD) in this group. In the patients with de-
compensated HF, the EDD was (6.78±0.24) cm,
while in the patients without decompensated HF,
it was (5.39±0.35) cm (p2<0.05) (normal ranges
for LVEDD are (4.54±0.32) cm (p1<0.05)) that re-
sulted in an increase in the EDV to (216.00±9.89) ml.
In the patients without decompensated HF, the EDV
was (138.9±9.95) ml (p2<0.05), while in healthy
individuals, it was (128.9±10.17) ml, respectively
(p1<0.05).
Changes in the indicators of LVPVT and IVST
were ambiguous. In the patients with decompen-
sated HF, LVPVTd was (1.36±0.12) cm (p1<0.05);
in the patients without decompensated HF, it was
(1.15±0.11) cm (p2<0.05); in healthy individu-
als, LVPVTd was (0.94±0.12) cm, respectively
(p1<0.05). In the patients with decompensated HF,
IVSTd was (1.28±0.1) cm (p1<0.05); in the pa-
tients without decompensated HF, it was
(1.13±0.11) cm (p2<0.05); in healthy individuals,
IVSTd was (0.89±0.12) cm, respectively (p1<0.05).
In the patients with decompensated HF, EF was
(40.57±2.22) %, that was significantly lower
(p1<0.05) as compared to the patients with prior MI
without HF (53.18±5.99) % (p2<0.05) and healthy
individuals (60.18±4.21) % (p1<0.05). The re-
duction in EF was combined with the increase in
S-wave amplitude and pulmonary artery pressure -
(88.14±4.2) mm Hg (p1<0.05) and
(37.88±4.04) mm Hg (p1<0.05).
In the patients with decompensated HF, LVMMI
was (234.76±7.14) g/m2 (p2<0.05); in the patients
without decompensated HF, it was (128.98±8.4) g/m2
(p1<0.05); normal ranges for LVMMI are
(76.41±10.88) g/m2 (p1<0.05) (Table 2). In the pa-
tients with decompensated HF, LVMM was
Dynamics of Indicators of Structural and Functional State of the Heart in the Post-Infarction
Period Depending on the Presence of Decompensated Heart Failure — 4/7
Table 1. Echocardiographic indicators in the patients with prior MI depending on the presence of
decompensated HF.
Indicator
Healthy individuals
(n=40)
Patients with prior MI
without decompensated
HF, (n=40)
Patients with prior MI
and decompensated HF,
(n=120)
EDV, ml 128.9±10.17
138.9±9.95 216.00±9.89
p1<0.05 p1<0.5
p2<0.05
ESV, ml 50.55±9.68
65.87±10.93 122.09±3.76
p1<0.05 p1<0.05
p2<0.05
EDD, cm 4.54±0.32
5.39±0.35 6.78±0.2
p1<0.05 p1<0.05
p2<0.05
ESD, cm 3.25±0.34
3.79±0.32 5.09±0.1
p1<0.05 p1<0.05
p2<0.05
IVSTs, cm 0.85±0.11
1.11±0.17 1.34±0.12
p1<0.05 p1<0.05
p2<0.05
IVSTd, cm 0.89±0.12
1.13±0.11 1.28±0.1
p1<0.05 p1<0.05
p2<0.05
LVPVTs, cm 0.92±0.11
1.17±0.13 1.48±0.12
p1<0.05 p1<0.05
p2<0.05
LVPVTd, cm 0.94±0.12
1.15±0.11 1.36±0.12
p1<0.05 p1<0.05
p2<0.05
EF, % 60.18±4.21
53.18±5.99 40.57±2.22
p1<0.05 p1<0.05
p2<0.05
Systolic output, ml 74.75±6.9
68.82±5.72 88.14±4.2
p1<0.05 p1<0.05
p2<0.05
Pulmonary artery
pressure, mm Hg
19.06±3.83
28.1±4.3 37.88±4.04
p1<0.05 p1<0.05
p2<0.05
Notes: statistically significant difference in the indicators:
p1 – as compared to healthy individuals;
p2 – as compared to the patients without decompensated HF.
(447.62±4.87) g that was significantly higher
(p2<0.05) as compared to the patients with prior MI
without CF (248.63±6.63) g (p1<0.05) and healthy
individuals (144.76±9.97) g (p1<0.05). According
Dynamics of Indicators of Structural and Functional State of the Heart in the Post-Infarction
Period Depending on the Presence of Decompensated Heart Failure — 5/7
Table 2. Indicators of LVMMI, LVMM and LV radius to wall thickness ratio in the patients with prior
MI depending on the presence of decompensated HF.
Indicator
Healthy individuals
(n=40)
Patients with prior MI
without decompensated
HF, (n=40)
Patients with prior MI
and decompensated HF,
(n=120)
LVMMI, g/m2 76.41±10.88
128.98±8.4 234.76±7.14
p1<0.05 p1<0.05
p2<0.05
LVMM, g 144.76±9.97
248.63±6.63 447.62±4.87
p1<0.05 p1<0..05
p2<0.05
Radius to wall
thickness ratio, c.u.
0.39±0.04
0.42±0.05 0.47±0.04
p1<0.05 p1<0.05
p2<0.05
Notes: statistically significant difference in the indicators:
p1 – as compared to healthy individuals;
p2 - as compared to the patients without decompensated HF.
to the indicators obtained, the radius to wall thick-
ness ratio was significantly higher (p2<0.05) in the
patients with decompensated HF – (0.47±0.04) c.u.
as compared to the patients without CF –
(0.42±0.05) c.u. (p1<0.05) and healthy individ-
uals – (0.39±0.04) c.u. (p1<0.05).
Among the hemodynamic indicators in the pa-
tients with decompensated HF, a significant reduc-
tion in EF and EDV, a tendency towards increase in
IVST and LVPVT, as indicated by LV systolic dys-
function, as well as myocardial hypertrophy and re-
modeling, significant pulmonary hypertension were
observed.
3. Conclusions
1. The indicator of EF plays a key role in se-
lecting management strategy for the patients
with CF, since a significant reduction in this
parameter indicates cardiac decompensation.
2. Modern management of patients with CHF
should be guided by an objective value of LF
EF, the increase in which should be regarded
as a predictor of CHF decompensation in the
post-infarction period, even without any clin-
ical signs.
3. The determination of pulmonary artery pres-
sure plays a significant role as well since most
patients with decompensated HF present with
mixed or passive pulmonary hypertension
due to vasoreactive response to passive in-
crease in the pressure.
4. Prospects of Further
Researches
Since the main hemodynamic parameters reflecting
the development of HF decompensation in patients
with prior AMI have been determined, we plan to
analyze their changes in the course of decongestive
therapy.
References
[1] Kovalenko VM, Nesukai OH, Titov YeYu et al.
Optimization of the diagnosis of heart failure
with preserved left ventricular ejection frac-
tion in patients with essential hypertension us-
ing speckle-tracking echocardiography. Ukrai-
inskyi kardiolohichnyi zhurnal. 2015;5:43-49.
[published in Ukrainian]
[2] Kuryata AV, Kushnir YuS. Direct influence on
the ischemic myocardium: studied and new op-
Dynamics of Indicators of Structural and Functional State of the Heart in the Post-Infarction
Period Depending on the Presence of Decompensated Heart Failure — 6/7
portunities. Ukraiinskyi kardiolohichnyi zhur-
nal. 2016;3:85-93. [published in Russian]
[3] Nascimento B, Brant L, Moraes D, Ribeiro
A. Global health and cardiovascular dis-
ease. Ukraiinskyi kardiolohichnyi zhurnal.
2016;(4):123-133. [published in Ukrainian]
[4] Yermak OS, Kravchun PH, Ryndina NH, Ryn-
chak PI. Copeptin, MRproADM and car-
diac hemodynamyc indicators in patients with
acute myocardial infarction depending on obe-
sity occurrence. Bukovinian Medical Herald.
2016;1(73):65-68. [published in Ukrainian]
[5] Chiew W, Chen S, Iyngkaran P. Cardiac
imaging in heart failure with comorbidi-
ties. Curr Cardiol Rev. 2017;13(1):63-65.
DOI: https://doi.org/10.2174/
1573403X12666160803100928 [PM-
Cid:PMC5324322]
[6] van Riet EE, Hoes AW, Wagenaar KP et
al. Epidemiology of heart failure: the preva-
lence of heart failure and ventricular dys-
function in older adults over time. A system-
atic review. Eur J Heart Fail. 2016;18:242-
252. DOI: https://doi.org/10.1002/
ejhf.483 [PMid:26727047]
[7] Kalogeropoulos AP, Georgiopoulou VV,
Gheorghiade M, Butler J. Echocardiographic
evaluation of left ventricular structure and func-
tion: new modalities and potential applications
in clinical trials. J Card Fail. 2012;18:159-
172. DOI: https://doi.org/10.
1016/j.cardfail.2011.10.019
[PMid:22300785]
[8] Gupta VA, Nanda NC, Sorrell VL. Role
of Echocardiography in the Diagnostic As-
sessment and Etiology of Heart Failure
in Older Adults: Opacify, Quantify, and
Rectify. Heart Fail Clin. 2017;13(3):445-
466. DOI: https://doi.org/10.1016/
j.hfc.2017.02.003 [PMid:28602365]
[9] Martens P, Nijst P, Mullens W. Current
approach to decongestive therapy in acute
heart failure. Curr Heart Fail. 2015;12:367-
378. DOI: https://doi.org/10.1007/
s11897-015-0273-5 [PMid:26486631]
[10] Marti CN, Georgiopoulou VV, Kalogeropoulos
AP. Acute heart failure: patient characteristics
and pathophysiology. Curr Heart Fail Rep.
2013;10:427-433. DOI: https://doi.
org/10.1007/s11897-013-0151-y
[PMid:23918642 PMCid:PMC3823818]
[11] Marwick TH. The role of echocardiography
in heart failure. J Nucl Med. 2015;56(6):31-
38. DOI: https://doi.org/10.2967/
jnumed.114.150433 [PMid:26033901]
[12] Papadimitriou L, Georgiopoulou VV, Kort
S, Butler J, Kalegeropoulos. Echocardio-
graphy in acute heart failure: current
perspectives. J Card Fail. 2016;22:82-
94. DOI: https://doi.org/10.
1016/j.cardfail.2015.08.001
[PMid:26277267]
[13] Ponikowski P, Voors AA, Anker SD et all.
ESC guidelines for the diagnosis and treatment
of acute and chronic heart failure: the task
force for the diagnosis and treatment of acute
and chronic heart failure of the European
Society of Cardiology (ESC). Developed
with the special contribution of the Heart
Failure Association (HFA) of the ESC. Eur
Heart J. 2016;37:2129-2200. DOI: https:
//doi.org/10.1002/ejhf.592
[PMid:27207191]
[14] Stranad M, Prosen, Borovnik LV. Bed-
side lung ultrasound for monitoring the
effectiveness of prehospital treatment with
continuous positive airway pressure in
acute decompensated heart failure. Eur
J Emerg Med. 2016;23(1):50-55. DOI:
https://doi.org/10.1097/MEJ.
0000000000000205 [PMid:25222428]
[15] Van Riet EE, Hoes AW, Wagenaar KP et
al. Epidemiology of heart failure: the preva-
lence of heart failure and ventricular dys-
Dynamics of Indicators of Structural and Functional State of the Heart in the Post-Infarction
Period Depending on the Presence of Decompensated Heart Failure — 7/7
function in older adults over time. A system-
atic review. Eur J Heart Fail. 2016;18:242-
252. DOI: https://doi.org/10.1002/
ejhf.483 [PMid:26727047]
[16] Yancy CW, Jessup M, Bozkurt B et al.
American College of Cardiology Founda-
tion; American Heart Association Task
Force on Practice Guidelines ACCF/AHA
guideline for the management of heart
failure. Circulation. 2013;128:240-327. DOI:
https://doi.org/10.1161/CIR.
0b013e31829e8807 [PMid:23741057]
Received: 2019-04-16
Revised: 2019-06-05
Accepted: 2019-06-18
